Skip to content

Efficacy of Different Electrical Stimulation Placement in Patients With Overactive Bladder Syndrome

Randomized,Single-Blind Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03516435
Enrollment
30
Registered
2018-05-04
Start date
2018-04-09
Completion date
2019-02-28
Last updated
2018-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder Syndrome

Keywords

Intravaginal electrical stimulation, Parasacral transcutaneous electrical stimulation

Brief summary

This experiment is expected to understand the benefits of different settings of electrical stimulation in the treatment of overactive bladder.

Detailed description

This experiment is expected to understand the benefits of different settings of electrical stimulation in the treatment of overactive bladder.The study will adopt a longitudinal research design with randomized quasi-experimental trial.The patients will recruited and be randomly assigned to Group A (Parasacral transcutaneous electrical stimulation) or Group B (Intravaginal electrical stimulation). There will be 30 participants in each group. Data will be collected 2 times.

Interventions

Asymmetrical biphasic square current pulse Frequency:10 Hz pulse width:1.0 ms Intensity:highest tolerable intensity(≦80 mA.) Parasacral transcutaneous electrical stimulation:Clinic using 2 superficial 3.5 cm electrodes placed on each side of S3 and S4.

DEVICEIntravaginal electrical stimulation

Asymmetrical biphasic square current pulse Frequency:10 Hz pulse width:1.0 ms Intensity:highest tolerable intensity(≦80 mA.) Intravaginal electrical stimulation:The electrode plug for vaginal plug was cylinder-formed with ring-formed placed into vaginal.

Sponsors

Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Urinary incontinence due to detrusor overactivity * No patients had been taking anticholinergics or tricyclic depressants and none had been treated by pelvic floor exercise, bladder training, or pelvic surgery before entry into the study.

Exclusion criteria

* stress incontinence * urinary tract infection * neurological disease * genital prolapse higher than stage II on POP-Q system * pregnancy * diabetes mellitus * a history of anti-incontinence surgery and/or prolapse repair * pelvic tumors and previously treated with radiation therapy or antimuscarinic agents * patients who were not cooperative * electrical stimulation contraindications

Design outcomes

Primary

MeasureTime frameDescription
3 Days Voiding diary3 daysThis chart is a record of your voiding and leakage or urine. Choose three (3) separate 24 hour periods to complete this record. Pick days which will be most convenient for you to measure every void.

Secondary

MeasureTime frameDescription
Overactive Bladder Symptom Score( OABSS)20 minThis is a single symptom score that employs a self-report questionnaire to quantify OAB symptoms.Questionnaire has many items with the same minimum and maximum score.Four question items, daytime frequency, nocturia, urgency and urgency incontinence, were included in the questionnaire according to the definition of OAB.
minVisual analogue scale (VAS) for urgency10 minThe Visual Analog or Analogue Scale (VAS) is designed to present to the respondent a rating scale with minimum constraints. Respondents mark the location on the 10-centimeter line corresponding to the amount of urgency they experienced. This gives them the greatest freedom to choose their urgency intensity. It also gives the maximum opportunity for each respondent to express a personal response style. VAS data of this type is recorded as the number of millimeters from the left of the line with the range 0-100.
Pad test20min-1hrTo measure leakage and may be performed in the specialist's office or at home. Pad testing can be done over a period of time as short as twenty minutes or up to one hour.

Countries

Taiwan

Contacts

Primary ContactChen Gin-Den, PhD
gdchentw@hotmail.com+886-4-24730022
Backup ContactChen Yi-Ching, MS
yiching@csmu.edu.tw+886-4-24730022

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026